Skip to main content

Table 3 Relationship between MVD, MVA, LVD or LVA and pathological variables in intratumoral area of Xp11.2 translocation RCC

From: Are tumor-associated micro-angiogenesis and lymphangiogenesis considered as the novel prognostic factors for patients with Xp11.2 translocation renal cell carcinoma?

Variables

No.

Intra-tumor (Mean ± SD)

MVD

P-value

MVA

P-value

LVD

P-value

LVA

P-value

Pathological T stage

  

0.023

 

< 0.001

 

0.718

 

0.664

 pT1/pT2

29

156 ± 10

 

41,933 ± 6967

 

1 ± 2

 

553 ± 602

 

 pT3/pT4

5

166 ± 4

 

57,750 ± 4244

 

1 ± 1

 

431 ± 260

 

Pathological N stage

  

< 0.001

 

< 0.001

 

0.615

 

0.911

 pN0

27

154 ± 9

 

41,212 ± 6658

 

1 ± 2

 

529 ± 604

 

 pN1

7

168 ± 5

 

56,008 ± 4630

 

2 ± 2

 

557 ± 408

 

Clinical M stage

  

0.017

 

0.001

 

0.690

 

0.837

 cM0

32

156 ± 10

 

43,329 ± 8083

 

1 ± 2

 

540 ± 575

 

 cM1

2

168 ± 1

 

59,139 ± 1477

 

1 ± 1

 

454 ± 445

 

AJCC stage

  

< 0.001

 

< 0.001

 

0.615

 

0.911

 I/II

27

154 ± 9

 

41,212 ± 6658

 

1 ± 2

 

529 ± 604

 

 III/IV

7

168 ± 5

 

56,008 ± 4630

 

2 ± 2

 

557 ± 408

 

WHO/ISUP grade

  

0.008

 

0.002

 

0.891

 

0.710

 1/2

24

154 ± 9

 

41,463 ± 7031

 

1 ± 2

 

559 ± 635

 

 3/4

10

164 ± 9

 

50,969 ± 8965

 

2 ± 1

 

478 ± 358

 
  1. MVD Microvascular density, MVA Microvascular area, LVA Lymph vessel area, LVD Lymph vessel density, AJCC American Joint Committee On Cancer, WHO/ISUP World Health Organization/International Society of Urological Pathology, Xp11.2 translocation RCC Xp11.2 translocation renal cell carcinoma
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us